These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24969172)

  • 1. Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer.
    Wen H; Kim YC; Snyder C; Xiao F; Fleissner EA; Becirovic D; Luo J; Downs B; Sherman S; Cowan KH; Lynch HT; Wang SM
    BMC Cancer; 2014 Jun; 14():470. PubMed ID: 24969172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can unknown predisposition in familial breast cancer be family-specific?
    Lynch H; Wen H; Kim YC; Snyder C; Kinarsky Y; Chen PX; Xiao F; Goldgar D; Cowan KH; Wang SM
    Breast J; 2013; 19(5):520-8. PubMed ID: 23800003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for comprehensive assessment of genetic predisposition in familial breast cancer.
    Lynch H; Synder C; Wang SM
    Breast J; 2015; 21(1):67-75. PubMed ID: 25472498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological features of 'BRCAX' familial breast cancers in the kConFab resource.
    Loughrey M; Provan PJ; Byth K; ; Balleine RL
    Pathology; 2008 Jun; 40(4):352-8. PubMed ID: 18446624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling.
    Hilbers FS; Meijers CM; Laros JF; van Galen M; Hoogerbrugge N; Vasen HF; Nederlof PM; Wijnen JT; van Asperen CJ; Devilee P
    PLoS One; 2013; 8(1):e55734. PubMed ID: 23383274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM gene.
    Tavera-Tapia A; Pérez-Cabornero L; Macías JA; Ceballos MI; Roncador G; de la Hoya M; Barroso A; Felipe-Ponce V; Serrano-Blanch R; Hinojo C; Miramar-Gallart MD; Urioste M; Caldés T; Santillan-Garzón S; Benitez J; Osorio A
    Breast Cancer Res Treat; 2017 Feb; 161(3):597-604. PubMed ID: 27913932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
    Aloraifi F; Alshehhi M; McDevitt T; Cody N; Meany M; O'Doherty A; Quinn CM; Green AJ; Bracken A; Geraghty JG
    Eur J Surg Oncol; 2015 May; 41(5):641-6. PubMed ID: 25736863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients.
    Rodríguez-Balada M; Roig B; Melé M; Albacar C; Serrano S; Salvat M; Querol M; Borràs J; Martorell L; Gumà J
    Clin Biochem; 2020 Feb; 76():17-23. PubMed ID: 31786208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer.
    Downs B; Kim YC; Xiao F; Snyder C; Chen P; Fleissner EA; Becirovic D; Wen H; Sherman S; Cowan KH; Lynch HT; Wang SM
    Breast Cancer Res Treat; 2015 May; 151(1):219-24. PubMed ID: 25833210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of pancreatic cancer in breast cancer families from the breast cancer family registry.
    Mocci E; Milne RL; Méndez-Villamil EY; Hopper JL; John EM; Andrulis IL; Chung WK; Daly M; Buys SS; Malats N; Goldgar DE
    Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):803-11. PubMed ID: 23456555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted sequencing to discover germline variants in the BRCA1 and BRCA2 genes in a Russian population and their association with breast cancer risk.
    Solodskikh SA; Panevina AV; Gryaznova MV; Gureev AP; Serzhantova OV; Mikhailov AA; Maslov AY; Popov VN
    Mutat Res; 2019 Jan; 813():51-57. PubMed ID: 30611917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique Features of Germline Variation in Five Egyptian Familial Breast Cancer Families Revealed by Exome Sequencing.
    Kim YC; Soliman AS; Cui J; Ramadan M; Hablas A; Abouelhoda M; Hussien N; Ahmed O; Zekri AN; Seifeldin IA; Wang SM
    PLoS One; 2017; 12(1):e0167581. PubMed ID: 28076423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family specific genetic predisposition to breast cancer: results from Tunisian whole exome sequenced breast cancer cases.
    Hamdi Y; Boujemaa M; Ben Rekaya M; Ben Hamda C; Mighri N; El Benna H; Mejri N; Labidi S; Daoud N; Naouali C; Messaoud O; Chargui M; Ghedira K; Boubaker MS; Mrad R; Boussen H; Abdelhak S;
    J Transl Med; 2018 Jun; 16(1):158. PubMed ID: 29879995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations and polymorphic BRCA variants transmission in breast cancer familial members.
    Pilato B; Martinucci M; Danza K; Pinto R; Petriella D; Lacalamita R; Bruno M; Lambo R; D'Amico C; Paradiso A; Tommasi S
    Breast Cancer Res Treat; 2011 Feb; 125(3):651-7. PubMed ID: 20352487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
    Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
    Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.
    Tazzite A; Jouhadi H; Nadifi S; Aretini P; Falaschi E; Collavoli A; Benider A; Caligo MA
    Gynecol Oncol; 2012 Jun; 125(3):687-92. PubMed ID: 22425665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).
    Tokunaga H; Iida K; Hozawa A; Ogishima S; Watanabe Y; Shigeta S; Shimada M; Yamaguchi-Kabata Y; Tadaka S; Katsuoka F; Ito S; Kumada K; Hamanaka Y; Fuse N; Kinoshita K; Yamamoto M; Yaegashi N; Yasuda J
    PLoS One; 2021; 16(1):e0236907. PubMed ID: 33428613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research.
    Neuhausen SL; Ozcelik H; Southey MC; John EM; Godwin AK; Chung W; Iriondo-Perez J; Miron A; Santella RM; Whittemore A; Andrulis IL; Buys SS; Daly MB; Hopper JL; Seminara D; Senie RT; Terry MB;
    Breast Cancer Res Treat; 2009 Jul; 116(2):379-86. PubMed ID: 18704680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models.
    Capalbo C; Ricevuto E; Vestri A; Ristori E; Sidoni T; Buffone O; Adamo B; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A; Giannini G
    Ann Oncol; 2006 Jun; 17 Suppl 7():vii34-40. PubMed ID: 16760289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.